NEW YORK, Jan. 29, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Third Avenue Focused Credit Fund (“Third Avenue,” the “Company” or the “Fund”) (Nasdaq:TFCIX) (Nasdaq:TFCVX) in the United States District Court for the Central District of California on behalf of a class consisting of all persons or entities who purchased the Third Avenue stock from March 1, 2013 to December 10, 2015. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Act of 1933 (the “Securities Act”).
The Complaint alleges that, in violation of the Securities Act of 1933, the prospectuses and registration statements of this fixed income mutual fund contained material false or misleading statements regarding its liquidity. According to the Complaint, Third Avenue promised investors that it would place no more than 15% of its assets in illiquid securities, securities that could not be sold promptly at or near its carrying value. The Complaint alleges that an analysis of the Fund’s holdings in 2013, 2014, and 2015 has revealed that the Fund consistently held more than 15% of its net assets in illiquid securities. According to the Complaint, the Fund’s excessive illiquidity meant that it could not promptly sell assets to meet growing redemptions without unloading them at fire sale prices, leading it to suspend redemptions and shut down the Fund on December 10, 2015.
If you wish to serve as lead plaintiff, you must move the Court no later than March 29, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 



